Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 80,000 shares at $73.22 ($5.8M) on 2025-05-02, disclosed to the SEC on 2025-05-05.
Scheduled sale ($5.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.52 | 18,480 | $1.3M | 23.0% |
| 2 | $72.52 | 18,480 | $1.3M | 23.0% |
| 3 | $73.22 | 21,520 | $1.6M | 27.0% |
| 4 | $73.22 | 21,520 | $1.6M | 27.0% |
| Total | $72.90 avg | 80,000 | $5.8M | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |